Global and Asia-Pacific Point-of-Care Diagnostics Market Report 2022: Market Expected to Reach USD 37.93 Billion in 2026

DUBLIN, March 11, 2022 /PRNewswire/ — The “Global Point-of-Care Diagnostics Market with a Focus on Asia Pacific: Overviews and forecasts with potential impact of COVID-19 (2022-2026)” report has been added to from ResearchAndMarkets.com offer.

Research and Markets Logo

The Global Point-of-Care Diagnostics Market is Expected to Reach US$37.93 billion in 2026, growing at a CAGR of 6.59% over the period 2022-2026

The growth of the market has been driven by factors such as rising global healthcare expenditure, growing geriatric population, escalating stress issues, increasing prevalence of chronic and infectious diseases, increasing use new immunoassay techniques. The market is expected to face certain challenges such as inadequate adoption of point-of-service devices and stringent regulatory policies.

To overcome these challenges, the market would witness some key trends such as the involvement of artificial intelligence, growing use of home blood glucose monitoring systems, mobile healthcare technologies, technological developments and portable and implantable devices.

The global point-of-care diagnostics market by application can be segmented as follows: blood glucose monitoring, hematology testing, pregnancy and fertility testing, cardiac marker testing, infectious disease testing, coagulation testing, blood glucose testing, urinalysis, tests for oncological markers and others. In 2021, the dominant market share was held by blood glucose monitoring. The point-of-care blood glucose monitoring market would grow, driven by the type 2 diabetic population.

The competitive landscape of the market, along with company profiles of key players (Abbott Laboratories, Becton Dickinson and Company, EKF Diagnostics Holdings plc, Danaher Corporation, Johnson & Johnson and F. Hoffmann-La Roche Ltd.) are also presented in detail.

In 2021, the dominant market share was held by North America.

Main topics covered:

1. Market overview
1.1 Point-of-Care Diagnosis
1.1.1 Presentation
1.1.2 History
1.2 Need for POC devices
1.2.1 Research and development in POC diagnostic devices
1.3 Types of POC devices
1.4 Types of POC tests
1.5 POC Diagnostics Product Categories
1.6 Advantages and disadvantages

2. Impact of COVID-19
2.1 Impact of COVID-19 on the Point-of-Care Diagnostics Market
2.2 COVID-19 Point-of-Care Diagnostics Market Impact
2.3 Post-COVID scenario

3. Global Market Analysis

3.1 Global Point-of-Care Diagnostics Market Forecast by Value
3.2 Global Point-of-Care Diagnostics Market by Application
3.2.1 Global Point-of-Care Glucose Monitoring Market Forecast by Value
3.2.2 Global Hematology Point-of-Care Testing Market Forecast by Value
3.2.3 Global Point-of-Care Pregnancy and Fertility Testing Market Forecast by Value
3.2.4 Global Point-of-Care Cardiac Marker Testing Market Forecast by Value
3.2.5 Global Point-of-Care Infectious Disease Testing Market Forecast by Value
3.2.6 Global Point-of-Care Coagulation Testing Market Forecast by Value
3.2.7 Global Point-of-Care Oncology Marker Testing Market Forecast by Value
3.2.8 Global Point-of-Care Urine Testing Market Forecast by Value
3.3 Global Point-of-Care Diagnostics Market by Region

4. Regional Market Analysis

4.1 North America
4.1.1 North America Point-of-Care Diagnostics Market Forecast by Value
4.2 Europe
4.2.1 Europe Point-of-Care Diagnostics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Point of Care Diagnostics Market Forecast by Value
4.3.2 Asia Pacific Point-of-Care Diagnostics Market by Application
4.3.3 Asia Pacific Point-of-Care Glucose Monitoring Market Forecast by Value
4.3.4 Asia Pacific OTC Point-of-Care Diagnostic Testing Market Forecast by Value
4.3.5 Asia Pacific Point-of-Care Infectious Disease Testing Market Forecast by Value
4.3.6 Asia Pacific Point-of-Care Cardiac Marker Testing Market Forecast by Value
4.3.7 Asia Pacific Point-of-Care Oncology Marker Testing Market Forecast by Value
4.3.8 Asia Pacific Point of Care Drugs of Abuse Market Forecast by Value
4.3.9 Asia Pacific Point-of-Care Blood Gas Testing Market Forecast by Value
4.3.10 Asia-Pacific Point-of-Care Pregnancy and Fertility Testing Market Forecast by Value
4.3.11 Asia-Pacific Point-of-Care Urinalysis Testing Market Forecast by Value
4.3.12 Asia-Pacific Point-of-Care Coagulation Testing Market Forecast by Value
4.3.13 Asia-Pacific Point-of-Care Hematology Testing Market Forecast by Value
4.3.14 Asia-Pacific Point-of-Care Ambulatory Chemistry Market Forecast by Value
4.3.15 Asia-Pacific Point-of-Care Decentralized Clinical Chemistry Market Forecast by Value
4.3.16 Asia-Pacific Point-of-Care Diagnostics Market by Region
4.3.17 Japan Point-of-Care Diagnostics Market Forecast by Value
4.3.18 tip of india Healthcare Diagnostics Market Forecast by Value
4.3.19 Malaysia Point-of-Care Diagnostics Market Forecast by Value
4.3.20 Thailand Point-of-Care Diagnostics Market Forecast by Value
4.3.21 Indonesia Point-of-Care Diagnostics Market Forecast by Value
4.3.22 Philippines Point-of-Care Diagnostics Market Forecast by Value
4.3.23 Vietnam Point-of-Care Diagnostics Market Forecast by Value
4.3.24 Singapore Point-of-Care Diagnostics Market Forecast by Value
4.4 Middle East & Africa
4.4.1 Middle East & Forecast of the Africa point-of-care diagnostics market by value
4.5 Latin America
4.5.1 Latin America Point-of-Care Diagnostics Market Forecast by Value

5. Market dynamics

5.1 Drivers of growth
5.1.1 Increase in the geriatric population
5.1.2 Rising Global Health Spending
5.1.3 Escalation of stress issues
5.1.4 Increased prevalence of chronic and infectious diseases
5.1.5 Growing use of new immunoassay techniques
5.2 Key Trends and Developments
5.2.1 Involvement of artificial intelligence
5.2.2 Increasing Use of Home Glucose Monitoring System
5.2.3 Mobile healthcare technologies
5.2.4 Technological developments
5.2.5 Wearable and implantable devices
5.3 Challenges
5.3.1 Inadequate adoption of POC devices
5.3.2 Strict regulatory policies

6. Competitive landscape

6.1 Global market
6.1.1 Revenue Comparison – Key Players
6.1.2 Market Cap Comparison – Key Players
6.1.3 Research and Development Expenditure Comparison – Key Players

7. Company Profiles

7.1 Company Overview
7.2 Financial overview
7.3 Business Strategies

  • Abbott Laboratories

  • Becton Dickinson and Company

  • EKF Diagnostics Holdings plc

  • Danaher Company

  • Johnson & Johnson

  • F. Hoffmann-La Roche Ltd.

For more information on this report, visit https://www.researchandmarkets.com/r/1uova2

Media Contact:

Research and Markets
Laura Woodsenior
press@researchandmarkets.com

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

Quote

Quote

Show original content:https://www.prnewswire.com/news-releases/global–asia-pacific-point-of-care-diagnostics-market-report-2022-market-is-anticipated-to-reach-37-93-billion -in-2026—increasing-use-of-new-immunoassay-techniques-301500887.html

SOURCE Research and Markets